Роль агонистов гонадотропин-рилизинг-гормона в комплексной терапии гиперпластических процессов репродуктивных органов

Ткаченко Людмила Владимирона, Свиридова Наталия Ивановна · Журнал акушерства и женских болезней · 2014

The aim of this study was to evaluate the efficacy of an agonist of gonadotropin-releasing hormone Buserilin in the treatment of patients with endometriosis in combination with endometrial hyperplasia. We conducted a clinical and laboratory examination and treatment of 108 patients aged 41 to 52 years old suffering from endometriosis varying degrees of prevalence in conjunction with endometrial hyperplasia. The results obtained suggest a scientifically sound complex treatment of patients with endometriosis on the background of endometrial hyperplasia with a GnRH agonist Buserilin-depo in the postoperative period, followed by the appointment of progestogens or combiened oral contraceptives as a long-term program management of patients to prevent relapse and re-operative treatment.

Cited by 0 works.

Authors